UK – MHRA suspends COVID-19 hydroxychloroquine trials

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) is suspending recruitment of patients in clinical trials involving hydroxychloroquine.

The move follows data from the RECOVERY trial showing no beneficial effect of the drug in patients hospitalised with COVID-19, as well as a New England Journal of Medicine publication that concluded it did not prevent illness compatible with COVID-19 or confirmed infection…